Blog

Perspectives in Breast and Colorectal Cancer Research


Dr. Charles Geyer discusses the NSABP B-59/GBG 96-GeparDouze trial

Charles Geyer, MD, Associate Director of Clinical Research at the VCU Massey Cancer Center

NSABP Foundation 0 539
Charles Geyer, MD, Associate Director of Clinical Research at the Virginia Commonwealth University Massey Cancer Center and NSABP Principal Investigator discusses immunotherapy and checkpoint inhibitors for breast cancer studies including the NSABP B-59/GBG 96-GeparDouze clinical trial.

Peter Lucas, MD, discusses the use of correlative science post-clinical trials

Peter Lucas, MD, Associate Professor of Pathology at the University of Pittsburgh and Director of Pathology at NSABP Foundation

NSABP Foundation 0 321

Peter Lucas, MD, Associate Professor of Pathology at the University of Pittsburgh and Director of Pathology and Principal Investigator at NSABP Foundation discusses the use of correlative science post-clinical trial and why clinical trials are important. (Interviewed October 2017 at the NSABP Foundation Annual Meeting in Chicago, IL.)

Jame Abraham, MD, discusses the importance of patient participation in clinical trials

By Dr. Jame Abraham, Director, Breast Oncology Program, Taussig Cancer Institute, Cleveland Clinic

NSABP Foundation 0 3797

Jame Abraham, MD, Director of the Breast Oncology Program at the Taussig Cancer Institute, Cleveland Clinic and a Principal Investigator with NSABP Foundation discusses his relationship with NSABP and the importance of patient participation in clinical trials research. (Interviewed October 2017 at the NSABP Foundation Annual Meeting in Chicago, IL.)

Exploring the Great Unknown with Dr. Tatjana Kolevska

Tatjana Kolevska, MD, Associate Director, Kaiser Permanente Oncology Clinical Trials Program

NSABP Foundation 0 676

Pushing the boundaries of science and knowledge both intrigue and motivate Dr. Tatjana Kolevska. Discovering “the great unknown” is a concept that appeals to her, and she says that if she did not practice medicine, she would love to be a space explorer.

Drs. Fisher and Wolmark receive SSO Distinguished Service Award

NSABP Foundation 0 432

Bernard Fisher, MD, Distinguished Service Professor at the University of Pittsburgh, and Norman Wolmark, MD, chairman of the NSABP Foundation, received the 2018 Distinguished Service Award from the Society of Surgical Oncology (SSO) on March 23 during the organization’s 71st Annual Cancer Symposium at McCormick Place Lakeside Center in Chicago, IL. Dr. Wolmark accepted the award on behalf of Dr. Fisher and himself from Dr. Jeffrey A. Drebin, SSO Past President.

RSS
123